Studies in middle-aged adults suggest that daily aspirin can reduce the risk of cancer, but it’s a different story for people aged 70 or older.The ASPREE study found no effect on overall cancer incidence for healthy older adults taking low-dose aspirin.In fact, during the period of the trial there was an elevated cancer mortality risk among participants taking the drug.Guest/sDr Suzanne Orchard, associate professor in the school of public health and preventative medicine at Monash UniversityReferencesCancer Incidence and Mortality With Aspirin in Older Adults: Follow-Up of the ASPREE TrialThe effects of daily low-dose aspirin on white matter hyperintensity lesions and retinal vascular calibre in healthy older adults: the ENVIS-ion exploratory neuroimaging substudy of the ASPREE randomised clinical trial

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related